Aurobindo Pharma board considers merger of subsidiaries
Approves filing of scheme of merger of Auro Vaccines with Curateq Biologics
The board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger of Auro Vaccines, a wholly owned step-down subsidiary of the Company with Curateq Biologics, a wholly owned subsidiary of the Company, with Hon'ble NCLT, Hyderabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content